Related Experiment Video
Updated: May 22, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
ADAR1-HNRNPL-Mediated CircCANX Decline Promotes Autophagy in Chronic Obstructive Pulmonary Disease
Ting-Ting Chen1,2, Yuan-Yuan Wei1,2, Jia-Ying Kang1,2
1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
This study identifies circCANX, a circular RNA that decreases in chronic obstructive pulmonary disease (COPD). Lower circCANX levels worsen COPD by increasing inflammation, suggesting circCANX as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Pulmonology
- Biochemistry
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory airway disease with limited treatment options.
- Circular RNAs (circRNAs) are emerging as key regulators in diseases, including COPD, offering potential therapeutic targets.
- Identifying novel molecular mechanisms in COPD is crucial for developing effective interventions.
Purpose of the Study:
- To identify and characterize novel circular RNAs involved in the pathogenesis of COPD.
- To investigate the role of circCANX in COPD progression and inflammation.
- To explore the potential of circCANX as a biomarker and therapeutic target for COPD.
Main Methods:
- Identification and quantification of circRNAs in COPD patient samples and cell/animal models.
- Investigation of the regulatory mechanisms controlling circCANX expression, including pre-mRNA splicing factors.
- Functional studies using in vitro and in vivo models to assess the impact of circCANX on COPD-related inflammation, autophagy, and stress granule formation.
- Mechanistic studies to elucidate how circCANX regulates gene expression via the nonsense-mediated mRNA decay (NMD) pathway.
Main Results:
- A nuclear circRNA, circCANX, was identified and found to be significantly decreased in COPD.
- The decline in circCANX is attributed to enhanced linear splicing of CANX pre-mRNA, mediated by the ADAR1-HNRNPL interaction.
- Higher circCANX expression correlated with better lung function (FEV1/FVC) in COPD patients.
- CircCANX was shown to suppress autophagy and stress granule formation, thereby mitigating COPD inflammation.
- Mechanistically, circCANX forms a complex with P53 mRNA and UPF1, promoting P53 mRNA degradation through NMD.
Conclusions:
- CircCANX plays a protective role in COPD by suppressing inflammation through the regulation of autophagy and stress granule formation.
- The circCANX-P53 mRNA-UPF1-NMD axis represents a novel regulatory pathway in COPD pathogenesis.
- CircCANX holds promise as a potential diagnostic biomarker and a therapeutic target for COPD drug development.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

